The National Institutes of Health (NIH) is offering a grant to support exploratory/developmental clinical research in the prevention or treatment of arthritis, musculoskeletal, and skin diseases. This Pilot and Feasibility Clinical Research Grant program enables initiation of short-term studies to investigate new ideas without stringent preliminary data. Its purpose is to gather critical preliminary data for future clinical trials. Studies may test new prevention strategies, interventions, or unique therapy combinations. A key objective is to stimulate the translation of promising research from the laboratory into clinical practice, fostering advancements in patient care for these conditions.
Opportunity ID: 249677
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-14-060 |
| Funding Opportunity Title: | Pilot and Feasibility Clinical Research Grants in Arthritis and Musculoskeletal and Skin Diseases (R21) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.846 — Arthritis, Musculoskeletal and Skin Diseases Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jan 03, 2014 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Nov 03, 2014 |
| Current Closing Date for Applications: | Nov 03, 2014 |
| Archive Date: | Dec 04, 2014 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $200,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses State governments Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Native American tribal governments (Federally recognized) Small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Public housing authorities/Indian housing authorities County governments Independent school districts |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This FOA encourages exploratory/developmental clinical research related to the prevention or treatment of arthritis and musculoskeletal and skin diseases, conditions, and/or injuries. The Pilot and Feasibility Clinical Research Grants Program is designed to allow initiation of exploratory, short-term clinical studies, so that new ideas may be investigated without stringent requirements for preliminary data. The short-term studies should focus on research questions that are likely to gather critical preliminary data in support of a future, planned clinical trial. They can include testing new or prevention strategies, a new intervention, or unique combinations of therapies. A high priority is the use of such studies to help stimulate the translation of promising research developments from the laboratory into clinical practice. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-14-060.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.846 | FORMS-C | Forms-C | PKG00191492 | Mar 07, 2014 | Nov 03, 2014 | View |
Package 1
Mandatory forms
249677 RR_SF424_2_0-2.0.pdf
249677 PHS398_ResearchPlan_2_0-2.0.pdf
249677 PHS398_CoverPageSupplement_2_0-2.0.pdf
249677 RR_KeyPersonExpanded_2_0-2.0.pdf
249677 RR_OtherProjectInfo_1_3-1.3.pdf
249677 PerformanceSite_2_0-2.0.pdf
Optional forms
249677 RR_SubawardBudget30_1_3-1.3.pdf
249677 PlannedReport-1.0.pdf
249677 PHS398_CumulativeInclusionReport-1.0.pdf
249677 PHS398_ModularBudget_1_2-1.2.pdf
249677 RR_Budget_1_3-1.3.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
